The scientific work of Walther Birkmayer is grounded on his ability to turn what was often a mass of clinical details into the basis for a hypothesis for a new therapeutic approach toward solving the problems of a patient's illness. Birkmayer first became known when, during the Second World War, he built up a clinic for brain injuries in Vienna, in which over 3000 patients were treated. The study of changes in the autonomic functions of the nervous system in these patients as well as the problems of rehabilitation were published in a monograph, "Hirn verletzungen". Consequently, this was his major scientific interest during the post-war years. His book, "Klinik und Therapie der vegetativen Funktionsstorungen" published with W. Winkler, brought Birkmayer recognition in the German-speaking world. In 1954 he took over the Neurological Department of the Geriatric Hospital of Vienna in Lainz, where he remained until his retirement in 1975. International acclaim followed his breakthrough with the clinical application of L-DOPA in Parkinson's disease. Birkmayer, as a strong adherent to the scientific interpretation of neurological and psychiatric disease, has encouraged multidisciplinary research. This is reflected in his establishment of the former Ludwig Boltzmann Institute of Neurochemistry, in which pharmacological, biochemical and histopathological research into neuropsychiatric diseases was performed under one roof. Further to his initial work on L-DOPA, Birkmayer has been in the forefront of supplementary parkinsonian therapy using enzyme inhibitors: benserazide in 1967, unselective monoamine oxidase inhibitors in 1962 and deprenyl in 1975.
Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.
Anbieter: Brook Bookstore On Demand, Napoli, NA, Italien
Zustand: new. Questo è un articolo print on demand. Bestandsnummer des Verkäufers PETCHBTRG1
Anzahl: Mehr als 20 verfügbar
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
Zustand: New. In. Bestandsnummer des Verkäufers ria9783709185841_new
Anzahl: Mehr als 20 verfügbar
Anbieter: Chiron Media, Wallingford, Vereinigtes Königreich
PF. Zustand: New. Bestandsnummer des Verkäufers 6666-IUK-9783709185841
Anzahl: 10 verfügbar
Anbieter: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Deutschland
Taschenbuch. Zustand: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -The scientific work of Walther Birkmayer is grounded on his ability to turn what was often a mass of clinical details into the basis for a hypothesis for a new therapeutic approach toward solving the problems of a patient's illness. Birkmayer first became known when, during the Second World War, he built up a clinic for brain injuries in Vienna, in which over 3000 patients were treated. The study of changes in the autonomic functions of the nervous system in these patients as well as the problems of rehabilitation were published in a monograph, 'Hirn verletzungen'. Consequently, this was his major scientific interest during the post-war years. His book, 'Klinik und Therapie der vegetativen Funktionsstorungen' published with W. Winkler, brought Birkmayer recognition in the German-speaking world. In 1954 he took over the Neurological Department of the Geriatric Hospital of Vienna in Lainz, where he remained until his retirement in 1975. International acclaim followed his breakthrough with the clinical application of L-DOPA in Parkinson's disease. Birkmayer, as a strong adherent to the scientific interpretation of neurological and psychiatric disease, has encouraged multidisciplinary research. This is reflected in his establishment of the former Ludwig Boltzmann Institute of Neurochemistry, in which pharmacological, biochemical and histopathological research into neuropsychiatric diseases was performed under one roof. Further to his initial work on L-DOPA, Birkmayer has been in the forefront of supplementary parkinsonian therapy using enzyme inhibitors: benserazide in 1967, unselective monoamine oxidase inhibitors in 1962 and deprenyl in 1975. 252 pp. Englisch. Bestandsnummer des Verkäufers 9783709185841
Anzahl: 2 verfügbar
Anbieter: Books Puddle, New York, NY, USA
Zustand: New. pp. 252. Bestandsnummer des Verkäufers 26142302156
Anzahl: 4 verfügbar
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
Paperback. Zustand: Brand New. 252 pages. 9.02x5.98x0.57 inches. In Stock. Bestandsnummer des Verkäufers x-370918584X
Anzahl: 2 verfügbar
Anbieter: Majestic Books, Hounslow, Vereinigtes Königreich
Zustand: New. Print on Demand pp. 252 31 Figures, 23:B&W 6 x 9 in or 229 x 152 mm Perfect Bound on White w/Gloss Lam. Bestandsnummer des Verkäufers 135062547
Anzahl: 4 verfügbar
Anbieter: Biblios, Frankfurt am main, HESSE, Deutschland
Zustand: New. PRINT ON DEMAND pp. 252. Bestandsnummer des Verkäufers 18142302150
Anzahl: 4 verfügbar
Anbieter: moluna, Greven, Deutschland
Zustand: New. Bestandsnummer des Verkäufers 5250801
Anzahl: Mehr als 20 verfügbar
Anbieter: buchversandmimpf2000, Emtmannsberg, BAYE, Deutschland
Taschenbuch. Zustand: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Parkinson's Disease: Unanswered Questions.- Blood Platelets as Models for Neurons: Uses and Limitations.- Changing Concepts of Nigral Dopamine System Function Within the Basal Ganglia: Relevance to Extrapyramidal Disorders.- An Autoradiographic Study of the Striatofugal Fibers in the Monkey.- Kinetics of L-DOPA Metabolism in the Caudate Nucleus of Cats with Ventrotegmental Lesions.- Spiro- peridol Binding in the Human Caudate Nucleus.- Quantitative Dissection of Human Brain Areas: Relevance to Transmitter Analyses.- On the Mechanism of the Antiparkinsonian Action of 1-DOPA and Bromocriptine: A Theoretical and Experimental Analysis of Dopamine Receptor Sub- and Super- sensitivity.- Contributions of - Adrenoreceptor Blockade to Extrapyramidal Effects of Neuroleptic Drugs.- The Decarboxylation of DOPA in the Parkinsonian Brain: In vivo Studies on an Animal Model.- Metabolic Alterations in an Animal Model of Huntington's Disease Using the 14C- Deoxyglucose Method.- Progressive Supranuclear Palsy: Clinico-Pathological and Biochemical Studies.- Clinical Analysis of Akinesia.- Akinetic Freezing and Trick Movements in Parkinson's Disease.- Distribution and Metabolism of the Potential Anti-Parkinson Drug Memantine in the Human.- Long-Term Responses of Parkinson's Disease to Levodopa Therapy.- Monoamine Oxidase Inhibitors as Anti-Depressant Drugs and as Adjunct to L-Dopa Therapy of Parkinson's Disease.- Dopamine Oxidation and Its Inhibition by (-)-Deprenyl in Man.- Dopamine Metabolism in Human Brain: Effects of Monoamine Oxidase Inhibition in vitro by (-)Deprenyl and (+) and (-)Tranylcypromine.- Unilateral Parkinson's Disease and Contralateral Tardive Dyskinesia: A Unique Case with Successful Therapy That May Explain the Pathophysiology of These TwoDisorders.- Lecithin in Parkinson's Disease.- Is the Neurosurgical Treatment of Parkinson's Disease Still Indicated .- Benign and Malignant Types of Parkinson's Disease: Clinical and Patho-Physiological Characterization.- Theoretical and Clinical Aspects of the Tourette Syndrome (Chronic Multiple Tic).- The Neuropathology of GABA Neurons in Extrapyramidal Disorders.- The Potential of GABA Mimetics in the Therapy of Extrapyramidal Disorders.Springer-Verlag KG, Sachsenplatz 4-6, 1201 Wien 252 pp. Englisch. Bestandsnummer des Verkäufers 9783709185841
Anzahl: 1 verfügbar